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1. Introduction 
This study is supported in part by a grant  from the National Natural Science Foundation of 
China (NSFC), key program 30930027. Corresponding to Wu RH. 
Alteration in tissue pH is an indicator of many pathological processes. In tumors, the pH 
gradient exists between the intracellular (pHi) and extracellular (pHe) compartments. pHe is 
usually lower, and pHi could be higher or unchanging compared with normal tissue, which 
can be correlated with prognosis and response to treatment. In recent years, non-invasive 
MR-based methods have been developed to assess tissue pH in brain tumors. In addition to 
protons (1H) and phosphorus (31P), pH measurement approaches have been applied with 
other NMR nuclei such as fluorine (19F) and carbon (13C). By using hyperpolarized 13C-
labelled bicarbonate, the average tumor interstitial pH was found significantly lower than 
the surrounding tissue in mouse tumor model. Gd (3+)-based pH sensors and chemical 
exchange-dependent saturation transfer δCESTε and paramagnetic (PARACEST) agents 
are useful for further delineation of brain tumors. We use an optimized CEST technique to 
provide non-invasive pH information for human brain tumors. This article primarily focuses 
on the measurement of pH in brain tumors with MR-based methods and relevant clinical 
potential. 
2. pH and tumours 
As we know, intra- and extracellular pH are regulated in a dynamic steady state driven by 
metabolic acid production, export of H+ from cells, and diffusion of these H+ equivalents 
from the site of production to the blood, where they are buffered by an open and dynamic 
CO2/HCO3- system[1]. However, although this balance is quite robust, many pathological 
states are associated with changes in tissue acid–base balance, including inflammation, 
ischaemia, renal disease, chronic lung disorders and intrauterine abnormalities [2-4] and 
tumors. In this review, we will focus on discussing pH alteration relevant to tumors.  
Evidence accumulated over the past 50 years and more has shown that electrode-evaluated 
human tumor pH is on average, lower than the pH of normal tissues [5-6]. The increase in 
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hydrogen ion concentration is thought to be due to a combination of a more glycolytic 
phenotype, as well as reduced oxygen availability, leading to lactic acidosis from glycolysis 
[7].In addition, a poor and chaotic tumor vascularization leads to the inefficient washout of 
the acidic products and contributes further to development of the chronically acidic 
extracellular environment [8]. However, although most tumors had relatively acidic 
extracellular pH, there were some exceptions. Engin et al reported that tumour pHe was 
significantly different between different histological groups, the mean tumour pHe for the 
entire group of tumours was 7.06 +/- 0.05 (range 5.66-7.78) [9]. Prior to the application of 
31P-MRS to living tissue, it was not recognized that tissue pH is compartmentalized into an 
intracellular component (pHi) and an interstitial or extracellular component (pHe) [10]. To 
our knowledge, currently, there weren’t concomitant measurements of pHi and pHe in 
spontaneous tumors. pH evaluated by electrodes primarily measures interstitial or 
extracellular tissue pH, whereas pH evaluated by31P-MRS primarily reflects the aggregate 
pHi of tissue. pHi is similar in tumors and normal tissue. To date, the majority of pHi values 
have been obtained using 31P-MRS. The measurement of pH by MRS is largely standardized, 
provides accuracy of±0.1 pH units [11]. The explaination is that the excess hydrogen ion is 
excreted from the cell by hydrogen ion pumps, in this way the intracellular environment is 
maintained at a more physiologically normal pH [5,12-13]. 
In recent years, there were some reports suggested that cellular uptake of chemotherapeutic 
drugs may depend on the pH gradient (pHi-pHe).The naturally occurring cell pH gradient 
difference between tumor and normal tissue is a major and exploitable determinant of the 
uptake of weak acids in the complex tumor microenvironment [14]. A low pHe enhances the 
uptake of weakly acidic drugs such as chlorambucil and 5-fluorouracil, whereas a low pHe 
reduces the uptake of mitoxantrone and the cytotoxicity of weakly basic drugs, such as 
doxorubicin [15-17]. By i.v.-injected glucose in a xenografted human tumor, Kozin [14] et al 
showed that the tumor-specific pH gradient may be exploited for the treatment of cancer by 
weak acid chemotherapeutics. Similarly, some efforts have been made to increase the 
intracellular acidity via disturbing the pH-regulating mechanisms, which therefore causing 
cell death at a sufficiently low pH [18-19]. To date, the majority of treatment-related studies 
conducted have focused on hyperthermia (combined with radiotherapy) due to the 
recognized importance of acidic pH as a thermal sensitizer. What surprised us for the results 
was that patients with a better response to hyperthermia radiotherapy have higher pH (as 
measured by electrode or 31P MRS) prior to treatment [20].  
3. pH measurement with 1H-MRSI 
With high inherent sensitivity of 1H nucleus, many attempts have been made to produce 
pH-sensitive MRI contrast. Gillies et al[1] have employed an exogenously administered 
imidazole, IEPA, which has a pH-dependent chemical shift of the H-2 resonance in the 7-9 
ppm range. This has been used for imaging pHe in orthotopic breast cancer by MR 
spectroscopic imaging (MRSI). Our colleagues [22] used conventional FSE sequence to study 
phantom (Histidine is included) and found there were some relationship between pH value 
and signal intensity on T2-weighted images, which enables the magnetic resonance pH 
imaging. 
Currently, there were two major approaches for measuring pH, relaxation methods and 
magnetization transfer methods. Relaxation methods requires the injection of exogenous 
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contrast agents (CAs). Actually, magnetic resonance spectroscopy with 31P or 19F probes can 
be attached to a contrast agent (CA). Nevertheless, although these probes can be effective, 
1H-based probes are preferred because they are intrinsically the most sensitive of MR-based 
probes. Current clinical CAs are small-molecule Gd3+ chelates that work by shortening the 
longitudinal and/or transverse relaxation times of the protons in their close proximity. 
These relaxation agents have a number of shortcomings. First, they do not target specific 
areas or disease regions, nor do they respond to cellular stimuli, but rather they matriculate 
throughout the body, confined to the circulatory system, prior to eventual elimination [23]. 
As a consequence, relatively large agent doses are required to reach clear contrast detection. 
Second, patients suffered gadolinium exposure have risk in with renal insufficiency [24]. 
The rapidly emerging field of molecular imaging seeks to develop CAs as molecular probes 
that respond to cellular processes or cellular markers in contrary [23]. To date, some recent 
prototype MRI CAs that respond to pH have been developed [25-28]. Gadolinium-based 
carbon nanostructures were poised to make a significant impact as advanced CAs for 
magnetic resonance imaging (MRI) in medicine. It was forecasted that gadonanotubes as 
synthons for the design of high-performance MRI CA probe with efficacies up to 100 times 
greater than current clinical CAs. These new materials will be useful for in vivo MRI 
applications as circulating drug nanocapsules because of their low toxicities, extremely high 
relaxivities, and potential for cellular targeting and induced cell death by magnetic 
hyperthermia [29]. In Hartman’s [23] study, gadonanotubes have also been shown to 
maintain their integrity when challenged ex vivo by phosphate-buffered saline solution, 
serum, heat, and pH cycling. Nevertheless, although these relaxation-based agents are 
responsive to the state of their environment (e.g. pH, temperature, etc.), the measured effect 
is a function of both the environment and the agent concentration, which is usually 
unknown in vivo, leading to the difficulty of quantification of the environmental parameter 
of interest [30]. In addition, only one target per MRI exam can be obtained with targeted 
relaxation contrast agents [31]. Considering the limitations of relaxation-based agents 
mentioned above, a new class of contrast agents is required. It was reported that use of 
chemical-exchange-dependent saturation transfer (CEST) methods in combination with 
agents possessing a proton exchange site can provide a significant change in the magnitude 
of the water proton signal, potentially providing a non-metal-based contrast mechanism 
[32]. 
When selecting a suitable CEST contrast agent, two characteristics including 
chemical exchange rate and longitudinal relaxation time must be considered. For maximum 
CEST efficiency, the chemical system must be exchanging slowly on the NMR chemical shift 
time-scale. A good CEST contrast agent must, therefore, possess mobile protons that 
exchange with water as fast as possible before exchange broadening makes selective RF 
presaturation ineffective. Larger frequency separations permit shorter proton lifetimes and 
thus result in larger CEST effects [30]. 
Currently, there are two major CEST contrast agents. The first CEST agents were 
diamagnetic small molecules (DIACEST) reported by Ward et al in 2000 [32], which contains 
exchangeable –NH or –OH protons. The major disadvantage of DIACEST agents is their 
small chemical shift difference between –NH and –OH groups and bulk water( <5ppm), 
which results in an overlap between the CEST effects of exogenous contrast agents and 
strong endogenous MT effects, and the activation of these exchange groups by semi-
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selective pulses usually also results in partial saturation of bulk water protons. Another kind 
of CEST agents are PARACEST agents, of which chemical shift difference between two 
exchanging pools can be increased as much as possible. One example of PARACEST agents 
are Lanthanide complexes. They are stable enough for in vivo applications and have one 
water molecule coordinated directly to the metal ion [33], which exchanges with the bulk 
water molecules. The rate of water exchange is in direct relationship to the metal ion’s 
requirement for electron density from the water molecule [33]. In more recent years, highly 
sensitive supramolecular and liposome-based CEST agents were developed by moving 
beyond the simple complex towards supramolecular structures. Two kinds of representative 
agents are ion-paired assemblies of poly-L-arginine and Tm3+-DOTP proposed by Aime and 
co-workers [34] and dubbed LIPOCEST which involves the incorporation of a shift reagent, 
such as Tm3+-DOTMA, inside a liposome [35]. To date, CEST agents present some 
challenges in terms of application to human studies. Although their theoretical detection 
limit may be lower than that of relaxation-based agents, their experimental detection limit 
remains higher, due to practical limitations [30]. 
Nowadays, there are some evdiences showing that it is possible to produce pH-sensitive 
MRI contrast by exploiting the exchange between the hydrogen atoms of water and the 
amide hydrogen atoms of endogenous mobile cellular proteins and peptides. It was 
reported that endogenous, low-concentration mobile proteins and peptides in tissue can be 
detected with amide proton transfer (APT) imaging technique via using a change in 
bulkwater intensity due to saturation transfer of the amide protons in the peptide bonds 
[36]. APT imaging is actually a variant of CEST imaging, of which the backbone is APT 
effect. To indicate the existence of APT effects, it was reported that there was a very small 
dip at frequency difference of 3.5 ppm from water, corresponding to about 8.3 ppm in the 
WEX spectra, where amide protons resonate [36]. Initial studies [37] have shown promise to 
distinguish tumor from surrounding brain in patients, but this data was hampered by 
magnetic field inhomogeneity and by low signal to noise ratio (SNR). Zhou [38] et al 
proposed a practical six-offset APT data acquisition scheme, together with a separately 
acquired CEST spectrum, which can provide B0-inhomogeneity corrected human brain APT 
images of sufficient SNR within a clinically relevant time frame. 
CEST imaging, however, is also dependent on experimental parameters such as the power, 
duration, and waveform of the irradiation RF pulse, for which, its sensitivity and specificity 
for microenvironment properties such as pH is not optimal. Animal models are always used 
to acquire Z-spectrum, from which we can observe the offset frequency away from water 
resonance center, and obvious APT effect. The Z spectrum can provide good evidence for 
what offset frequency should be applied. However, there are still many problems about how 
to optimize pulse sequence for improving SNR and imaging contrast. Thus, in addition to 
search for better CAs, some researchers are working directly at improving pulse sequence 
technology. In Sun et al’s study [39], they solved the dependence of CEST contrast on 
experimental parameters and proposed an iterative compensation algorithm that corrects 
the experimentally measured CEST contrast from the concomitant RF irradiation effects, 
thereby to accurately calibrate the chemical exchange rate. 
In all, APT imaging could provide important biomarker for assessing many diseases. 
However, due to the low amide protons concentration (in the millimolar range), low signal-
to-noise ratio, motional artifacts and so on, more efforts should be made to reach good APT 
imaging. 
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4. Measurement of pH with 31P MRSI 
It is reported that brain energy metabolism can be assessed by using 31P MRS to measure 
changes in the intracellular pH and relative concentrations of adenosinetriphosphate (ATP), 
phosphocreatine (PCr), and inorganic phosphate (Pi) [40-41]. By calculating from the 
difference in chemical shifts between Pi and PCr resonances, pH values can be obtained. As 
we know, although both the intracellular and extracellular compartments of tissue contain 
phosphate, they are different in the concentration, with 2-3 mM in intracellular 
compartment and 1.0 mM in extracellular compartment. Dimethyl methyl phosphate 
(DMMP) is a colorless liquid with chemical formula C3H9O3P or CH3PO(OCH3)2. It 
distributed among all the water spaces. 3-aminopropylphosphonate (3-APP) has a pKa in 
the physiological range and accesses only the extracellular compartment. Both DMMP and 
3-APP are chemically inert and non-toxic. With these materials as markers for total and 
extracellular water spaces respectively, non-invasively measuring the intra- and 
extracellular volume fraction can be accomplished [42]. For greater intracellular volume 
fraction and relative higher concentration of phosphate of intracellular volume, the chemical 
shift of the endogenous Pi resonance is generally assumed to reflect intracellular pH. Under 
physiological conditions, the change in intracellular pH produced by unit change in 
extracellular pH ranges from 0.4 to 0.8 [43-44]. 
In tumors, pHi of tumor cells in situ is neutral or slightly alkaline compared with that of 
normal tissues. Thus comparisons of intracellular pH values between systems are 
meaningless without knowledge of the extracellular pH [45]. Measurements of pHe in 
tumors have been made using an invasive microelectrodes technique. Some argument was 
that this invasive probe may change relative volume of cell and artifactually increase the 
extracellular pH. Some agents have been reported to be used as a 31P-MRS indicator of 
extracellular pH, however, these have not also been fully developed for use in vivo [46-48]. 
pH indicators for in vivo use should meet some criteria which include no toxic or cytostatic 
effects, a pK, in the physiological range, a clearly separable signal, demonstrable 
localization, specificity to pH, and a large pH sensitivity [48]. An agent satisfies all these 
criteria is 3-APP. 3-APP is non-toxic and has a pKa in the physiological range, and in vitro 
results indicate that its resonant frequency is sensitive to pH and not significantly affected 
by temperature or ionic strength. Bioreactor experiments indicate that this compound is 
neither internalized nor metabolized by cells [45]. In additon, the clear separation of this 
signal from the cellular phosphate resonances allows extracellular pH to be measured more 
accurately than with extracellular Pi [45,48]. By intraperitoneally administering 3-APP , 
Gillies [45] et al carried out experiments in vivo which sucessfully demonstrated the use of 
3-APP as a 31P-MRS-based indicator of extracellular pH in cells and tissues.  
5. Measruement of pH with hyperpolarized 13C MRSI 
13C magnetic resonance spectroscopy (MRS) has long been used in the investigation of 
metabolic processes in vivo [49]. 13C nuclear magnetic resonance (NMR) spectroscopy 
allows  
observation of the backbone of organic compounds, yielding specific information about the 
identity and structure of biologically important compounds [50].With a broad chemical shift 
range for carbon (250ppm), which is much larger than that for proton (15 ppm), it allows for 
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improved resolution of metabolites. However, 13C MRS is limited by the low natural 
abundance of 13C (1.1%) and its very low nuclear spin polarization (2.5×10-6 polarization at 
3 T and 37ºC) [51-52].  
Several techniques have been used to overcome these limitations. One way to improve the 
sensitivity of 13C spectroscopy is to perform a technique known as proton (1H) decoupling. 
By eliminating these couplings, the signal-to-noise ratio of 13C resonances can be 
significantly increased via irradiating the entire 1H NMR absorption range, consequently 
collapsing 13C resonances to singlets [50]. Another technique to improve the sensitivity of 
13C MRS is dynamic nuclear polarization (DNP), which introduces one or more 13C 
molecules into a metabolic substrate [53]. DNP has emerged recently as a technique for 
radically increasing the sensitivity of solution-state 13C MRS [54]. When DNP is performed 
in a strong magnetic field and at cryogenic temperatures, nearly 100% nuclear polarization 
for 1H and 50% for 13C can be achieved in various organic molecules. In addition, replacing 
the 12C isotope (98.9% natural abundance) with the 13C isotope at a specific carbon or 
carbons in a metabolic substrate does not affect the substrate’s biochemistry [52]. There are 
four mechanisms accounted for in the DNP process: the overhauser effect, the solid effect, 
thermal mixing, and the cross effect or electronuclear crosspolarization [55]. In general, the 
DNP experiments are conducted at low temperatures，by which to attenuate competing 
spin-lattice relaxation processes and avoid loss of efficiency during the polarization transfer 
[56]. It was reported that the sensitivity in the 13C MRS experiment can be increased by 
10,000-fold or more by using DNP technique, which allows not only detection of 13C-labeled 
substrates in vivo but imaging of their tissue distribution as well [57-59]. Preclinical model 
clearly demonstrated the feasibility of obtaining high-spatialresolution 13C MRSI data with a 
high signal-to-noise ratio from tumor implanted mice injected by injecting the animals with 
hyperpolarized 1-[13C] pyruvate [59].  
A new application for DNP is for measuring extracellular tissue pH using hyperpolarized 
13C labelled bicarbonate. Gallagher et al [60-61] generated a non-toxic, pH-probe, 
hyperpolarized H13CO3- and exploited the pH in tumors. With measurement of the H13CO3- 
and 13CO2 concentration ratio after administration of hyperpolarized H13CO3-, tissue pH 
could be determined by using the Henderson-Hasselbalch equation [62]: 
 pH=pKa+log10([HCO3-]/[CO2]) (1) 
(pKa is assumed to be known in vivo) 
6. Measruement of pH with 19F NMR 
19F NMR has several distinct strengths: a large chemical shift range, high gyromagnetic 
ratio, no background signal from tissues inherently 12.5 times the sensitivity of 31P NMR 
[63]. Ojugo et al [64] compare the effect of pHe measurements made by the 31P probe (3-
APP) with those made by the 19F probe, 3-[N-(4-fluor-2-trifluoromethylphenyl)-
sulphamoyl]-propionic acid (ZK-150471). Result showed, with wide chemical shift range, 
improved signal-to-noise and absence of signal overlap, 19F pH probe ZK-150471 allowed a 
more rapid and precise measurement of pHe compared to 3-APP. Development of 
exogenous NMR pH indicators opens the opportunity to exploit 19F nuclei. There were some 
evidences showing Fluorinated vitamin B6 derivatives have been developed for 19F NMR 
methods to study cellular pHi and pHe. 6-FPOL (29fluoro-5- hydroxy-6-methyl-3,4-
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pyridinedimethanol, 6-fluoropyridoxol) is one example. pH values are calculated from the 
19F spectra on the basis of chemical shift of 6-FPOL (δobs) with respect to a NaTFA (sodium 
trifluoroacetate) standard. Substituting (δobs) into the Henderson-Hasselbalch equation with 
coefficients pka=8.2; δacid=-9.85; δbase=-19.61 and the pH is estimated [65]: 
 pH=pKa+log10[δobs·δacid/δbase·δobs] (2) [66]. 
Mason et al [65] have demonstrated 6-FPOL readily enters cells and provides well resolved 
resonances reporting both intra- and extracellular simultaneously in whole blood), and the 
perfused rat heart. As mentioned above, the pKa of 6-FPOL is 8.2. It is appropriate for 
monitoring pH in the basic range, whereas it is not ideal for measurements under normal 
physiological conditions. There were some studies on modifications of vitamin B6 
suggesting that the introduction of electron donating or withdrawing groups at the 4- and 5-
positions of thepyridoxol ring could significantly alter the pKa of the 3-phenolic group, and 
the NMR properties at the 6-position [67]. He et al [68] have synthesized a series of novel 
fluorinated vitamin B6 analogues (6-fluoropyridoxol derivatives) as potential 19F NMR pH 
indicators for use in vivo. The variation in chemical shift with respect to acid±base titration 
showed pKa values in the range 7.05±9.5 with a chemical shift sensitivity in the range 7.4±12 
ppm. Among them, 6-Fluoropyridoxamine (6-FPAM) exhibits a pKa=7.05, which is closer to 
normal physiological pH than the parent molecule 6-FPOL (pKa=8.2), and should thus, be 
useful for precise and accurate measurements of pH in vivo [68].  
7. Summary 
Alteration in tissue pH is an indicator of many pathological processes, such as 
inflammation, ischaemia, renal disease, chronic lung disorders and intrauterine 
abnormalities and tumors. In tumors, the pH gradient exists between the intracellular (pHi) 
and extracellular (pHe) compartments. pHe is usually lower, and pHi could be higher or 
unchanging compared with normal tissue. Some evidences reaveal that cellular uptake of 
chemotherapeutic drugs may be depend on the pH gradient, which therefore, may help 
monitor tumour progression and evaluate drug treatment response. To date, pH 
measurement approaches have been applied with some NMR nuclei such as protons (1H), 
phosphorus (31P), fluorine (19F) and carbon (13C). 31P-MRS has low spatial resolution (20-
30ml) and is not available on standard clinical equipment, which is limited predominantly 
(99%) to proton (1H) studies [36]. Currently, it is usually used as a control experiment when 
carrying 1H or 13C MRS study. The rapid development of contrast agents and improvement 
on technology attracts researchers to devote their effort on 1H–MRSI for exploiting pH. As a 
variant of CEST imaging, APT imaging can detects endogenous, low-concentration mobile 
proteins and peptides in tissue using a change in bulkwater intensity due to saturation 
transfer of the amide protons in the peptide bonds with or without the need for exogenous 
contrast agents. DNP technique introduces one or more 13C molecules into a metabolic 
substrate to improve the sensitivity of 13C MRS. Based on this technology, a non-toxic, pH-
probe is generated by intravenous injecting hyperpolarized H13CO3-. Nevertheless, the 
current standard clinical MRI scanners can’t perform 13C MRS, the addition of the ability to 
detect nuclei other than 1H represents an added cost, and the clinical motivation to date has 
not been adequately demonstrated [50]. To date, due to the low amide protons 
concentration (in the millimolar range), low signal-to-noise ratio, motional artifacts and so 
on, to reach a good APT imaging may require long stage of development. 
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(Courtesy of Dr Jinyuan Zhou and Elsevier) 
Fig. 1. MR images acquired on a Philips 3 T MRI scanner (Achieva 3.0 T; Philips Medical 
Systems, Best, The Netherlands) from a patient with recurrent astrocytoma (grade III), 
acquired four months after treatment. (a), (b) T2-weighted image and T1-weighted image 
show the recurrence of glioma with heterogeneous intensity in the left parietal lobe. The 
exact location of the tumor core is obscure. (c) Post-contrast T1-weighted image reveals a 
gadolinium-enhancing tumor core (red arrow) and a necrotic area (pink arrow). The 
recurrent tumor is associated with the surrounding edema and mass effect. (d) APT image 
shows an obvious increase in APT signal intensity in the tumor core. The regions of necrosis 
(pink arrow) and edema (orange arrow) are almost isointense on APT.  
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(Courtesy of Dr Jinyuan Zhou and Elsevier) 
Fig. 2. MR images for another patient with glioblastoma multiforme. (a), (b) T2-weighted 
image T1-weighted image show a large tumor of abnormal signals in the left frontal lobe. (c) 
Gadolinium-enhanced T1-weighted image demonstrates an enhancing tumor core (red 
arrow) with non-enhancing necrotic areas. (d) APT image shows that both the gadolinium-
enhancing tumor core (red arrow) and the cystic cavity (black arrow) have high APT signal 
intensities, while the necrotic regions (pink arrow) and edema areas (orange arrow) have 
low APT signal intensities.  
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(Courtesy of  Dr Kevin M. Brindle)  
Fig. 3. 13C spectrum  from a murine lymphoma (EL4) tumour in vivo, acquired 10 s after the 
intravenous injection of hyperpolarized H13CO3-, showing resonances from H13CO3- (at 
161 p.p.m.) and 13CO2 (at 125 p.p.m.). 
 
(Courtesy of  Dr Kevin M. Brindle)  
Fig. 4. The spatial distribution of 13CO2 and H13CO3- in a transverse slice was imaged using a 
gradient echo pulse sequence. A shows transverse proton magnetic resonance image of a 
mouse with a subcutaneously implanted EL4 tumour. Tumor is margined in red. B shows the 
pH map calculated from the ratio of the H13CO3-  and 13CO2 voxel intensities ,which 
demonstrated a low intratumoral pH. C and d show the spatial distribution of H13CO3- and 
13CO2, displayed as voxel intensities relative to their respective maxima, respectively. the 
highest concentration of 13CO2 was in the tumour and the H13CO3- signal was highest in the 
aorta and there was little difference in signal intensities between muscle and tumour. The 
tumour margin in b, c and d is outlined in white. 
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(Courtesy of Dr Ralph Mason) 
Fig. 5. Struture of 6-FPOL(6-fluoropyridoxol)  
 
 
a 
 
B 
(Courtesy of Dr Ralph Mason) 
Fig. 6. a 282MHz 19F NMR spectrum of 6-FPOL in whole unwashed rabbit 
blood:pHi=7.19(δ=-10.72ppm).pHe 7.45(δ=-11.34ppm). ΔpH=0.26(Δδ=0.62ppm) with 
respect to external NaTFA capillary standard. 6b 376MHz 19F NMR spectrum of 6-FPOL in 
a sanguinous perfused rat heart: pHi=7.16(δ=-10.60ppm).pHe 7.55(δ=-11.64ppm). 
ΔpH=0.39(Δδ=1.04ppm) with respect to external NaTFA in balloon in left ventricle.  
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a 
 
b 
(Courtesy of Sha He and Elsevier) 
Fig. 7. a 19F NMR spectrum of 6-FPAM in water at pH 6.9 (δ=-13.57 ppm). 7b Spectrum of 6-
FPAM in whole rabbit blood. Two signals are observed for 6-FPAM attributed to intra (δ=-
14.793 ppm) and extra (δ=-16.935 ppm) cellular compartments corresponding to pH 7.16 and 
7.59, respectively. A capillary of sodium TFA served as external chemical shift reference. 
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